These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6093666)

  • 1. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
    De Marco A; Manca B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):91-6. PubMed ID: 6093666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of a new cephalosporin: ceftriaxone (RO 13-9904) in resurgent acute and chronic bronchopneumopathies].
    Pezza A; Giacomelli P; Montella R; Casino G
    Arch Monaldi; 1983; 38(1-2):17-24. PubMed ID: 6326701
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ceftriaxone (Rocéphine) in major African infectious pathology. Results at the Niamey Hospital (Niger) ].
    Rey JL; Konarjevski R; Madras R; Ousseini A; Félix H
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):513-6. PubMed ID: 6289228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute respiratory infections in childhood with a new cephalosporin, ceftriaxone].
    Berni Canani M; Leone L; Della Rotonda G; Palazzi A
    Pediatr Med Chir; 1984; 6(2):277-80. PubMed ID: 6099551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice daily ceftriaxone therapy for serious bacterial infections in children.
    Chonmaitree T; Congeni BL; Munoz J; Rakusan TA; Powell KR; Box QT
    J Antimicrob Chemother; 1984 May; 13(5):511-6. PubMed ID: 6330022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concentration of antibiotics in various jaw tissues: concentration of ceftriaxone (Part IX)].
    Pignanelli M; Fraschini F; Santoro F; Scaglione F; Tassarotti B
    Dent Cadmos; 1984 Aug; 52(8):69-71. PubMed ID: 6098488
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
    Eron LJ; Goldenberg RI; Poretz DM
    Am J Surg; 1984 Oct; 148(4A):1-4. PubMed ID: 6091473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 15. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of a new cephalosporin ceftriaxone (Ro 13-9904) in sepsis and other infectious forms of particular severity].
    Calonghi GF; Vezzani F
    G Ital Chemioter; 1981; 28(1-2):55-9. PubMed ID: 6290304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fundamental study on tissue distribution of ceftriaxone in the field of obstetrics and gynecology].
    Fukuda O; Miyamura S; Inoue S; Maeyama M
    Jpn J Antibiot; 1984 Dec; 37(12):2416-9. PubMed ID: 6098737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the intravenous administration of cefmenoxime in pediatric field].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Nakazawa S; Chikaoka H; Oka S
    Jpn J Antibiot; 1982 Oct; 35(10):2393-404. PubMed ID: 6306291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with ceftizoxime suppositories in pediatrics].
    Kobashi H; Nishioka A; Miyamoto N; Ohara K; Okamoto T
    Jpn J Antibiot; 1985 Oct; 38(10):2932-42. PubMed ID: 3866087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone in the treatment of infections caused by Staphylococcus aureus in children.
    Nelson SJ; Boies EG; Shackelford PG
    Pediatr Infect Dis; 1985; 4(1):27-31. PubMed ID: 3969363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.